Cipla Q2 Profit Drops 35% as Revenue and EBITDA Weaken
The drugmaker’s quarterly profit fell to Rs 878 crore, while its One India business reported growth across several segments.
Makkler Newsroom · Oct 27, 12:09 PM · 1 min read
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO